Ketchum is a leading global communications consultancy with operations in more than 70 countries across six continents. London, the consultancy’s European hub and largest office in the region, brings together specialists in health, corporate reputation, public affairs, consumer and brand communications, as well as sustainability and influencer marketing.
Ketchum Health has a track record of 20+ years supporting clients in the life sciences industry across Europe and beyond. It works with start-ups, multinational corporations, patient advocacy groups, medical associations and public authorities at a local, national and international level. The team embeds truly diverse backgrounds and expertise, ranging from PhD-level scientists to PR, reputation management, corporate affairs, advocacy and value communications specialists, who operate in close collaboration with other in-house experts (including Research & Analytics, Digital Marketing, Issue & Crisis Management) and colleagues from the wider network.
For more information on Ketchum, a part of Omnicom Public Relations Group, visit www.ketchum.com.
The Healthcare Communications Association proactively represents and champions on behalf of the healthcare communications sector.
A not-for-profit organisation, with membership comprising in-house teams, agencies, not-for-profits and individuals working in national and global healthcare communications across diverse business sectors, the HCA provides the collective voice to establish, maintain and improve best practice and quality standards in our speciality.
As the accreditor of continuing professional development in healthcare communications, the HCA takes the leading role in providing education and shared learning, helping organisations and individuals develop their professional skills.
With cross-industry membership, the HCA also aims to provide unique business intelligence and networking opportunities for its members.
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
Our industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. We represent companies who supply more than 80 per cent of all branded medicines used by the NHS and who are researching and developing the majority of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome disease.
Globally our industry is researching and developing more than 7,000 new medicines.
The ABPI is recognised by government as the industry body negotiating on behalf of the branded pharmaceutical industry for statutory consultation requirements including the pricing scheme for medicines in the UK
Please contact Anna on +44 (0)20 8267 4126 or email@example.com.
Sponsorship and exhibition opportunities
Please contact Steve on +44 (0)20 8267 8092 or firstname.lastname@example.org.
Please call +44 (0)20 8267 4011 or email email@example.com.